A board of cancer professionals made a recommendation Wed on the narcotic Avastin. The board determined that Avastin should not be authorized by the Food and drug administration for the treatment of breast cancer. The panel determined that the drug has extreme side effects and is ineffective. The FDA will make a final conclusion in July.
Avastin's second trial
This is the subsequent time a group has ruled negatively on the cancer drug. Avastin didn't help improve cancer patients' lives according to the panel's conclusion last Dec. Roche did demonstrations on this though. It meant a subsequent hearing was required.
CR4 Admin: Modified Post
Copyright Violation: Reduced copied text according to copyright law. Please see Section 12 of the CR4 FAQ about posting copyrighted material.
Citations
Huffington Post
huffingtonpost.com/2011/06/28/avastin-breast-cancer-patients_n_886217.html
CNBC
cnbc.com/id/43582047
Forbes
forbes.com/feeds/ap/2011/06/29/health-health-care-us-breast-cancer-drug-fda_8541968.html